Group One Trading
ACIU icon

Group One Trading’s AC Immune ACIU Stock Holding History

Group One Trading’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,074
Closed -$75.2K – 7176
2024
Q3 		$91K Buy
24,074
+4,677
+24% +$16.3K ﹤0.01% 4247
2024
Q2 		$77.4K Buy
19,397
+18,946
+4,201% +$62.7K ﹤0.01% 4157
2024
Q1 		$1.33K Buy
+451
New +$1.62K ﹤0.01% 6575
2023
Q4 		– Sell
-5,255
Closed -$16.9K – 7288
2023
Q3 		$15K Buy
5,255
+2,243
+74% +$6.83K ﹤0.01% 6101
2023
Q2 		$8.9K Buy
+3,012
New +$6.57K ﹤0.01% 6453
2021
Q3 		– Sell
-5,577
Closed -$39.9K – 8092
2021
Q2 		$44K Buy
+5,577
New +$38.5K ﹤0.01% 6691

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Group One Trading's ACIU Position: Q4 2024 in Review

Group One Trading sold out of AC Immune (ACIU) in Q4 2024, closing a stake of 24,074 shares — an estimated $75.2K sold.

Group One Trading first reported a position in ACIU in Q2 2021 and held it in 6 quarters. The position peaked at $91K in Q3 2024. 45 funds tracked by Wall St. Rank hold ACIU as of Q4 2024.

  • Group One Trading reported no remaining AC Immune position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 24,074 AC Immune shares in Q4 2024, an estimated $75.2K.
  • Group One Trading first reported a position in AC Immune in Q2 2021 and held it in 6 quarters.
  • Group One Trading's AC Immune position peaked at $91K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held AC Immune as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.